Skip to main content

Your search for “Novel Treatment” returned 433 results

Liangfang Zhang Makes MIT Technology Review’s Annual Innovators Under 35 List

August 21, 2013

MIT Technology Review has named Liangfang Zhang, a professor of nanoengineering at the University of California, San Diego, among the top 35 young innovators of 2013. For over a decade, the global media company has recognized a list of exceptionally talented technologists whose work has great potential to transform the…

A Potential New Target for Head and Neck Cancer Immunotherapy

March 13, 2023

UC San Diego researchers have identified a strong association between the product of a gene expressed in most cancers and elevated levels of white blood cells that produce antibodies within tumors, suggesting a new therapeutic target.

The Coming of Age of Stem Cell Therapy

October 30, 2014

…patients to pursue potential treatments for spinal cord injury, Type 1 diabetes and chronic lymphocytic leukemia. And last week, the California Institute for Regenerative Medicine (CIRM), the state stem cell agency established by Prop.71, named the Sanford Stem Cell Clinical Center at UC San Diego Health System one of three…

Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity

April 30, 2020

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

What Happens When We Pass Out? Researchers ID New Brain and Heart Connections

November 1, 2023

UC San Diego researchers have for the first time identified the genetic pathway between the heart and brain tied to fainting. In a new study published in the journal Nature, they found that vagal sensory neurons trigger fainting, laying a foundation for addressing fainting-related disorders.

David A. Brenner, MD, to Step Down as Vice Chancellor for Health Sciences

December 15, 2021

Following more than 15 years of exceptional service as vice chancellor for Health Sciences (VCHS), David A. Brenner, MD, will step down on June 30, 2022 to focus on teaching and research as a member of the School of Medicine’s faculty.

New Grant Funds Clinical Trial to Assess Psychedelic as Treatment for Phantom Limb Pain

February 17, 2021

The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.

BPA’s Real Threat May Be After It Has Metabolized

October 4, 2012

Bisphenol A (BPA) is a synthetic chemical widely used in the making of plastic products ranging from bottles and food can linings to toys and water supply lines. When these plastics degrade, BPA is released into the environment and routinely ingested. New research from the University of California, San Diego…

UC San Diego Heart Transplant Program Boasts Nation’s Best Survival Rates

August 7, 2019

The heart transplant program at UC San Diego Health has demonstrated the best one-year survival rate for patients in the United States among health care providers with a volume of more than 50 heart transplants per year, according to the Scientific Registry of Transplant Recipients.

Evolution May Be to Blame for High Risk of Advanced Cancers in Humans

December 8, 2020

Compared to chimpanzees, our closest evolutionary cousins, humans are particularly prone to developing advanced carcinomas — the type of tumors that include prostate, breast, lung and colorectal cancers — even in the absence of known risk factors, such as genetic predisposition or tobacco use.

Category navigation with Social links